SKAFF MICHAEL C enters VIVOS THERAPEUTICS, INC. with 1.34M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 6/20/2025ACC: 0002074003-25-000001
1.34M
Baseline shares
0.00
Direct ownership
0 positions
8.98M
Derivative underlying
4 instruments
2
Security positions
1.34M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned828K
Common Stock
IndirectShares owned514.50K
Total
1.34M indirect1.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 828K | Indirect |
| Common Stock | 514.50K | Indirect |
| Total | 1.34M | 1.34M indirect |
Derivative Holdings4
Pre-Funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
725.26K
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Common Stock Purchase Warrant
IndirectUnderlying security
Common Stock
Underlying shares
2.33M
Shares owned
N/A
Exercise price
2.23
Expiration
—
Exercise window
—
Common Stock Purchase Warrant
IndirectUnderlying security
Common Stock
Underlying shares
3.22M
Shares owned
N/A
Exercise price
2.204
Expiration
—
Exercise window
—
Pre-Funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
2.71M
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
8.98M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-Funded Warrant Indirect | Common Stock | 0.0001 | — | — | 725.26K | N/A |
| Common Stock Purchase Warrant Indirect | Common Stock | 2.23 | — | — | 2.33M | N/A |
| Common Stock Purchase Warrant Indirect | Common Stock | 2.204 | — | — | 3.22M | N/A |
| Pre-Funded Warrant Indirect | Common Stock | 0.0001 | — | — | 2.71M | N/A |
| Total | 8.98M | 0.00 | ||||